All In Biotech

Free tool

FAERS Monitor: Sovuna

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214581 or its brand name (Sovuna, Hydroxychloroquine Sulfate). Reports on generic versions are filed under their own applications.

Reports

40,482

Serious

35,382

87% of reports

Hospitalization

11,485

Death reported

4,537

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective18,316
  • rheumatoid arthritis13,898
  • pain10,999
  • fatigue9,608
  • drug intolerance9,402
  • off label use8,673
  • arthralgia8,566
  • joint swelling8,555
  • contraindicated product administered8,205
  • alopecia7,852
  • abdominal discomfort7,845
  • rash7,825
  • systemic lupus erythematosus7,352
  • arthropathy7,333
  • synovitis7,068

Reports by year received

View as table
YearReports
2004173
2005231
2006174
2007243
2008402
2009368
2010660
2011421
2012723
2013208
2014143
2015370
2016904
20171,044
20181,597
20193,281
20207,825
20215,384
20224,541
20232,948
20243,572
20253,390
20261,880

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,013,677 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
synovitisSignal7,068334.1324.81,429,101
contraindicated product administeredSignal8,205192.7188.21,142,597
systemic lupus erythematosusSignal7,352135.4132.3779,301
arthropathySignal7,33378.877.0490,198
rheumatoid arthritisSignal13,89872.371.3862,621
drug intoleranceSignal9,40255.954.9459,758
joint swellingSignal8,55539.638.8300,402
abdominal discomfortSignal7,84525.424.9176,976
alopeciaSignal7,85221.621.2149,449
arthralgiaSignal8,56610.910.777,017
rashSignal7,8259.59.359,508
painSignal10,9999.59.384,115
drug ineffectiveSignal18,3167.37.2104,916
fatigueSignal9,6086.56.445,657
off label useSignal8,6735.25.130,284

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.